A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal published a study in July 2011 reporting “risk of serious adverse cardiovascular events associated with varenicline.” UCSF researchers, however, question the way the previous study was conducted, and their new analysis, scheduled to be published May 4 in BMJ, reaches a very different conclusion.
April 09, 2012
A UCSF-led effort to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the Food and Drug Administration.
March 16, 2012
The California Institute for Quantitative Biosciences (QB3) has renewed and expanded a three-year agreement with Pfizer Inc. to collaborate on research projects at the University of California with the potential to transform world-class science into better medicine.
November 16, 2011
UCSF’s new robotic pharmacy has won a 2011 Best of What’s New award for innovation from Popular Science.
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
September 07, 2011
Researchers with the University of California, San Francisco and the University of California, Merced will examine the effectiveness of state and local anti-smoking programs across the United States to ensure that health authorities are able to use their increasingly limited resources to support and defend the most effective approaches.
August 22, 2011
Children with severe asthma are 3.6 times more likely to have been exposed to tobacco smoking before birth – even without later exposure – than children with a mild form of the disease, according to a multicenter study led by researchers at University of California, San Francisco (UCSF).
March 07, 2011
UCSF has opened an automated hospital pharmacy believed to be the nation’s most comprehensive facility using robotic technology and electronics to prepare and track medications with the goal of improving patient safety.
February 28, 2011
UCSF and Zcube have entered into a new agreement to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.
December 13, 2010
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.